SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-764311
Filing Date
2016-11-09
Accepted
2016-11-09 16:03:03
Documents
54
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d240882d10q.htm 10-Q 382257
2 EX-31.1 d240882dex311.htm EX-31.1 8218
3 EX-31.2 d240882dex312.htm EX-31.2 8203
4 EX-32.1 d240882dex321.htm EX-32.1 4280
  Complete submission text file 0001193125-16-764311.txt   3125489

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cbay-20160930.xml EX-101.INS 666013
6 XBRL TAXONOMY EXTENSION SCHEMA cbay-20160930.xsd EX-101.SCH 37362
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20160930_cal.xml EX-101.CAL 52243
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20160930_def.xml EX-101.DEF 113488
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20160930_lab.xml EX-101.LAB 303111
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20160930_pre.xml EX-101.PRE 211943
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36500 | Film No.: 161984190
SIC: 2834 Pharmaceutical Preparations